MGTA - Magenta Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $3.49. This is a potential upside of $-9.73 (-73.6%) from yesterday's end of day stock price of $13.22.

Magenta Therapeutics's activity chart (see below) currently has 13 price targets and 11 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 68.52% with an average time for these price targets to be met of 154.56 days.

Most recent stock forecast was given by YUN ZHONG from BTIG on 26-Jan-2023. First documented stock forecast 25-Mar-2019.

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 26-Jan-2023

$3

2 years 11 months 16 days ago
(26-Jan-2023)

2/3 (66.67%)

$-2.8 (-48.28%)

266

Buy

Since 08-Mar-2022

$3

$-8.19 (-73.19%)

$9

2 years 11 months 16 days ago
(26-Jan-2023)

1/2 (50%)

$-4.04 (-57.39%)

287

Hold

$2

$1.3 (185.71%)

$7

3 years 4 months 17 days ago
(25-Aug-2022)

1/3 (33.33%)

$0.13 (6.95%)

14

Buy

Since 18-Apr-2022

$8

$-3.19 (-28.51%)

3 years 8 months 24 days ago
(18-Apr-2022)

1/1 (100%)

$-22.72 (-73.96%)

246

Buy

Since 18-Apr-2022

$8

$-3.19 (-28.51%)

$17

3 years 8 months 24 days ago
(18-Apr-2022)

2/2 (100%)

$-22.72 (-73.96%)

137

Show more analysts

Please expand the browser size to see the chart

What is MGTA (Magenta Therapeutics) average time for price targets to be met?

On average it took 154.56 days on average for the stock forecasts to be realized with a an average price target met ratio 68.52

Which analyst has the current highest performing score on MGTA (Magenta Therapeutics) with a proven track record?

YUN ZHONG

Which analyst has the current lower performing score on MGTA (Magenta Therapeutics) with a proven track record?

TERENCE FLYNN

Which analyst has the most public recommendations on MGTA (Magenta Therapeutics)?

Yun Zhong works at WEDBUSH and has 2 price targets and 1 ratings on MGTA

Which analyst is the currently most bullish on MGTA (Magenta Therapeutics)?

Paul Choi with highest potential upside - $3.78

Which analyst is the currently most reserved on MGTA (Magenta Therapeutics)?

David Nierengarten with lowest potential downside - -$8.19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?